PROIETTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 591
EU - Europa 501
AS - Asia 144
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.238
Nazione #
US - Stati Uniti d'America 590
IE - Irlanda 130
IT - Italia 104
SE - Svezia 69
UA - Ucraina 64
HK - Hong Kong 42
SG - Singapore 38
KR - Corea 33
FI - Finlandia 29
RU - Federazione Russa 25
DE - Germania 24
CN - Cina 23
NL - Olanda 20
GB - Regno Unito 14
FR - Francia 9
CH - Svizzera 3
IN - India 3
LB - Libano 3
AT - Austria 2
GR - Grecia 2
IR - Iran 2
RO - Romania 2
AU - Australia 1
BE - Belgio 1
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
PL - Polonia 1
Totale 1.238
Città #
Chandler 153
Dublin 130
San Mateo 72
Hong Kong 42
Altamura 38
Medford 28
Princeton 28
Seoul 28
Wilmington 26
Lawrence 25
Perugia 24
Ann Arbor 23
Singapore 21
Beijing 18
Des Moines 18
Andover 15
Saint Petersburg 12
Falls Church 11
Mondolfo 10
Ashburn 9
Boardman 8
Jacksonville 4
Redwood City 4
Florence 3
Lausanne 3
Marino 3
Rome 3
San Paolo di Civitate 3
Woodbridge 3
Bucharest 2
Helsinki 2
Mcallen 2
Moscow 2
Norwalk 2
Ponte 2
Brussels 1
Buffalo 1
Centro 1
Crespino 1
Fairport 1
Frankfurt am Main 1
Houston 1
Lonigo 1
Los Angeles 1
Ottawa 1
Paris 1
Philadelphia 1
Portland 1
Praia A Mare 1
Prato 1
Sydney 1
Vienna 1
Totale 794
Nome #
The efficacy and safety of a multimodal therapy for chronic prostatitis/chronic pelvic pain: a prospective randomized study 97
IncobotulinumtoxinA in the treatment of neurogenic detrusor overactivity. 79
“Efficacy and tolerability of fesoterodine fumarate in the treatment of overactive bladder symptoms in patients affected by Multiple Sclerosis: Long term follow up”. 69
Clinical and urodynamic efficacy of Xeomin in the treatment of neurogenic detrusor overactivity: preliminary results. 67
Botulinum Toxin A Modulates Afferent Fibers in Neurogenic Detrusor Overactivity 66
OnabotulinumtoxinA intravesical treatment in patients affected by overactive bladder syndrome: best practice in real-life management 64
Botulinum toxin Type-A activity in prostate cancer 55
Desmopressin in the treatment of nocturia in patients affected by neurogenic bladder 53
Botulinum toxin a enters normal human urothelial cells and modulates the sensory activity of bladder urothelium 52
Vesical urothelium and new concepts 49
Overactive bladder and sexual function: a nightmare couple 48
OnabotulinumtoxinA intradetrusorial injections modulates bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity 46
Single-session Supine Bilateral Percutaneous Nephrolithotomy 43
Normal human urothelial cell lines express onabotulinumtoxinA SV2 high affinity receptors. 42
OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results 42
ONABOTULINUM TOXIN A INTRADETRUSORIAL INJECTION MODALITY: SHALL WE TAKE A REST? 41
Contemporary management of the painful bladder: a systematic review. 37
TRATTAMENTO RIPETUTO CON MULTIPLE INFILTRAZIONI INTRADETRUSORIALI DI ONABOTULINUMTOSSINA A IN PAZIENTI AFFETTI DA VESCICA IPERATTIVA REFRATTARIA: RISULTATI A LUNGO TERMINE. 37
Desmopressin in the treatment of nocturia in patients affected by Parkinson's disease 36
Is retrograde intrarenal surgery for the treatment of renal stones with diameters exceeding 2 cm still a hazard? 36
Onabotulinumtoxin-A intradetrusorial injections modulate bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity 35
Cystoman® and calculi: a good alternative to standard therapies in preventing stone recurrence. 34
Chronic prostatitis: How to give our best without apposite vagueness 34
Six-year follow-up of intradetrusorial injections of botulinum toxin type a in patients with refractory neurogenic detrusor overactivity: Clinical and urodynamic results 32
Urinary symptoms and sexual dysfunction in patients affected by multiple sclerosis 28
Reply to Claus Riedl's Letter to the Editor re: Antonella Giannantoni, Vittorio Bini, Roger Dmochowski, et al. Contemporary Management of the Painful Bladder: A Systematic Review. 25
Resonance(A (R)) metallic stent in patients with ureterocutaneostomies 24
Overactive bladder 23
Totale 1.294
Categoria #
all - tutte 5.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202090 2 12 7 2 3 1 31 4 17 5 5 1
2020/2021146 2 11 8 12 58 15 4 1 17 8 7 3
2021/2022221 5 49 0 10 6 7 1 70 5 4 22 42
2022/2023481 31 99 9 45 32 53 0 15 166 2 18 11
2023/2024138 14 18 8 2 0 1 44 0 0 3 26 22
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 1.294